Latest filing published 14 Jun 2023 for Swedish Orphan Biovitrum AB (publ), €4,354.
Filing timeline
BuySaleInsider track record
No signal scores available.
Pablo de Mora: trading record in brief
Pablo de Mora discloses dealings in Swedish Orphan Biovitrum AB (publ) to Finansinspektionen. The record holds 3 filings, all for trades on 9 June 2023.
Sales make up the whole of the open-market record (1 sale, €4,354). The rest of the record consists of 2 share grants.
The record was last updated on 14 June 2023 with an open-market sale (€4,354) in Swedish Orphan Biovitrum AB (publ). The median gap between a trade and its publication by Finansinspektionen is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pablo de Mora
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 230 shares@ SEK 220.60100.0% of flowAktieISIN SE0000872095FI:csv-c0cc5fb6e0805a24913a
- 3,182 shares0AktieISIN SE0000872095FI:csv-a7750165f8181244f472
- 2,952 shares0AktieISIN SE0000872095FI:csv-e974afbe399924540a23
3 of 3 declarations